Summary:
Ulcerative Colitis doesn’t have to determine the memories you make.
If you are living with ulcerative colitis, our clinical research study may be for you.
Our team of medical professionals is evaluating an oral investigational drug called filgotinib to see if it reduces the signs and symptoms of UC by lowering the immune response that causes inflammation in the digestive system.
Qualified Participants Must:
• Be eligible to participate in a long-term extension study
•
Try an oral investigational drug to see if it reduces the signs and symptoms of UC
Qualified Participants May Receive:
- Receive study drug and monitoring from a local study doctor at no cost
- Receive reimbursement for study-related travel expenses